Anxiety relief during surgery: esketamine shows promise in new trial

NCT ID NCT06530706

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study tested whether the drug esketamine can reduce anxiety in 185 patients undergoing abdominal tumor surgery. Patients received either esketamine or a placebo during and after surgery. Researchers measured anxiety levels, sleep quality, and recovery to see if esketamine helps patients feel calmer and recover better.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
esketamine
What this could lead to
If it works, this could offer a way to reduce anxiety and improve recovery for patients undergoing abdominal tumor surgery.
What could go wrong
This is a small, completed trial without published results yet. Esketamine may cause side effects like dizziness or nausea, and its benefit over standard care is not confirmed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY STATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zhejiang cancer hospital

    Hangzhou, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.